The present study was aimed at developing a soft chewable dosage form for calcium carbonate for nutraceutical application. Two diŠerent types of the formulations viz., sugar based and sugar free soft chews were prepared. The eŠect of various ingredients on the diŠerent organoleptic characteristics (grittiness, sweetness, hardness and mouthfeel) and the emulsion stability of the dosage form were checked and evaluated on the basis of an in-house numerical scale on healthy human volunteers. The study revealed that the type of emulsifying agent, heating temperature, particle size of the drug, ratio and quantity of sugars were found to have signiˆcant impact on the organoleptic characteristics of the dosage form. The study also indicates that the proper selection of packaging material is important in order to maintain the long term integrity of the formulation.
INTRODUCTION
Most of the drugs given orally have bitter or non palatable taste, 1, 2) which is the most common cause of non-compliance among patients. 3) Various methods such as drug particle coating, 4, 5) encapsulation, 6) complexation 7) and chemical modiˆcation 8) have been utilized to mask the bitterness. However, these techniques are complex and extensive optimization is required for their practical application and, therefore, cost eŠective and simple taste masking technology needs to be developed.
Most commonly used method for masking the taste of the drug is to add masking agents to powders, liquids, mouth dissolving or chewable tablets. 9 11) Chewable and mouth dissolving formulations are more suitable for paediatric and geriatric patients with a swallowing problem, over the liquid and powder forms which are di‹cult to handle. However, chewable tablets have additional advantage of high drug dose carrying capacity over mouth dissolving dosage form because of minimal requirement of superdisintegrants. Ideally, chewable formulations have smooth texture upon disintegration, pleasant taste and no bitter or unpleasant aftertaste. Upon chewing, they are broken down in the mouth and release their ingredients in the process and therefore, do not have much lag time as required for the disintegration of tablets before absorption from stomach. 12) The various categories of drugs which may be incorporated as soft chewable drug delivery systems (SCDDS) are vitamins, mineral supplements, antacids, unpalatable drugs such as aspirin, ibuprofen, cimetidine, acetaminophen, erythromycin etc. These formulations can be readily chewed before swallowing without feeling the bitterness, unpleasant taste or odour of these unpalatable compounds. Mineral supplements (MS) available in the market as hard chewable tablets have a gritty mouthfeel and unpleasant aftertaste which can be overcome by formulating such ingredients as SCDDS for better taste and palatability. 13) Delivery of MS for treatment of mineral deˆ-ciency with the help of the soft chewable tablets can be helpful, specially to encourage children to easily accept MS in a tasty candy clothing. This dosage form also solves the dosage size problem which results from the higher dose of the MS. Therefore, the present work was designed to develop a SCDDS of a high dose MS, calcium carbonate (CC) with a pleasant mouthfeel and taste. The main objectives of this investigation were thus, to mask the grittiness and overcome the unpleasant taste of the drug, to optimize the quantities of the necessary excipients such as emulsiˆ-ers, oils and sugars to obtain a soft chew with optimum hardness and to optimize the processing conditions including temperature and stirring rate. 
MATERIALS AND METHODS

Materials
The following materials were purchased and used as received. CC form Sigma Aldrich (Gurgaon, India). Other chemicals used were of analytical grade and were purchased locally.
Formulation Method
The formulation was prepared in a stepwise manner as follows:
1. Preparation of O/W Emulsion GMS was melted in mixed vegetable oil by heating. CC in the required dose, was dispersed in water to form a slurry/ paste and this slurry was added to oil phase with constant stirring at 1500 rpm to form a paste like w/o emulsion. A little excess water was then added to cause phase inversion of the emulsion to o/w type.
2. Preparation of W/O/W Emulsion Sugar was dissolved completely in minimum amount of water with no crystal of sugar remaining undissolved followed by liquid glucose with isomalt dissolved in it. In case of sugar free formulation, isomalt, other polyols and sucralose were dissolved in water. Condensed milk with the required amount of emulsiˆer, Tween 80 or soya lecithin was added to the sugar syrup phase followed by salt (sodium chloride) for enhancing ‰avour. The mixture was heated with constant stirring till a light brown colour was obtained. Temperature was increased gradually and carefully to avoid the loss of excess water to reach the desired candy stage. The prepared o/w emulsion of step 1 was then added to it under stirring and the temperature was gradually increased till 121° 125°C to obtain thê rm ball stage.
Preparation of the Soft Chew
The prepared hot mixture of step 2 was poured into a stainless steel tray and cooled to room temperature. It was then kneaded like dough for graining the soft chew and wasˆnally moulded and cut into pieces of required weight and shape to obtain the soft chew tablets. Graining is a process in which the sucrose crystals tend to aggregate to decrease the free movement of the molecules and improve the fracture and chewable property of the formulation.
The eŠect of various variables like ratio of sugar to L-glucose, GMS/Soy lecithin ratio, particle size of CC and heating temperature was studied on physical characteristics and palatability of sugar based formulations ( Table 1) while eŠect of variables like amount of sucralose, Isomalt/MaltisweetMH80 ratio, sor- In all the sugar free batches, the particle size of drug is 75 mm. B11 and B12 have same composition as that of B2. The heating temperature for batches B1 B10 is 121 125°C and of B11 and B12 is 115 120°C and 126 130°C, respectively.  Maltisweet MH80 has 25 moisture, 70 maltitol, 3 sorbitol, so percentage calculated on the basis of  w/w of theˆnal formulation after heating.  Final water content of the soft chew should not be more than 10. bitol and GMS concentration and heating temperature was studied in case of sugar free formulations ( Table 2) .
Evaluation Techniques Evaluation of Physical Characters of the Formulation
Taste evaluation of the soft chews was performed by consensus of trained taste panel of the three age groups of healthy volunteers on the basis of feedback. The organoleptic properties of the tablets viz. grittiness, sweetness and mouthfeel and its physical property viz. hardness, were evaluated and rated according to an in-house numerical scale ( Table 3) .
The tablets were chewed in mouth for 60 s by each volunteer and the response was recorded using the numerical scale. After 60 s, the chew was spitted out and the mouth was rinsed thoroughly with mineral water.
CC Content Analysis
Test solution was prepared by dissolving 10 soft chews in 400 ml water. 50 ml of concentrated hydrochloric acid was added followed by sonication of the sample to dissolve the carbonate salt. The mixture was heated on the hot plate and volume was made up with water and shaken vigorously. The solution was thenˆltered through Whatmanˆlter paper (No. 1). 10 ml of theˆltrate was taken and diluted to 100 ml. 15 ml of 0.1N NaOH solution was added along with the indicator, hydroxy naphthol blue. This sample was then titrated against 0.05M EDTA solution (previously standardized), to obtain a blue colored end point.
Mineral salt equivalent to elmental mineral (in mg/ chew) ＝ Volume of EDTA used×2.004×M×1000
(no. of chews) 10×0.05×10
(1) Similar solution prepared using dummy soft chews was used as blank. Batches B2 and Bs2 were analyzed for their drug content.
Drug Dissolution Study Dissolution study was carried out on six units using USP Dissolution Apparatus II using 900 ml of 0.1N HCl as dissolution medium maintained at 37 ±0.5°C temperature and 50 rpm stirring rate. The tablets wereˆrst gently crushed using a mortar and pestle to mimic the in vivo chewing process and the powdered content (passing through sieve of A.S.T.M #20) equivalent to the weight of one tablet was then subjected to dissolution study. 10 ml of aliquots were withdrawn at predetermined intervals (15 and 30 min),ˆltered using Whatmanˆlter paper (No.1) and the CC content was estimated titrimetrically.
Stability Studies
To assess long term stability 14) of the prepared dosage form, formulations were packed separately in sealed high density polypropylene (HDPE) bottles and aluminium strips, and stored at 40°C/75％ relative humidity (RH) in the stability chamber (Narang Scietiˆc Works Pvt. Ltd., New Delhi, India) for 3 months. The samples were withdrawn at diŠerent time intervals (1, 2, and 3 months) and observed for their assay and moisture content using Karlˆsher instrument (Metrohm, USA). The results were supported by statistical analysis using student`t' test and ANOVA (signiˆcance level p＜0.05).
RESULTS AND DISCUSSION
The success of a SCDDS is based on its ability to appeal the taste and mouthfeel of the patients. Unfortunately, no standard techniques are available to evaluate the characteristics speciˆc to these kind of dosage forms. Therefore, the present investigation involving the development of soft chewable tablets was evaluated on the basis of an in-house numerical scale for rating the diŠerent organoleptic characteristics (grittiness, sweetness, hardness and mouthfeel) and the emulsion stability of the dosage form ( Table 3) .
Sugar Based Formulations EŠect of Ratio of Sugar to L-Glucose on Hardness
With the increase in the ratio of sugar/L-glucose at constant heating temperature (Batch Bs1, Bs2 and Bs3), the hardness of theˆnal formulation increased ( Fig. 1(A) ). This is attributed to sugar which is solid in nature and has very low moisture content which imparts hardness while L-glucose has a higher moisture content imparting softness to the chew. Upon evaluation of these three batches, batch Bs2 was found to have optimum sugar to L-glucose ratio with respect to hardness, sweetness and mouthfeel. Therefore, moisture content of the excipients plays an important role in the overall hardness as well as it would also contribute to the long term physical stability of the product.
EŠect of Heating Temperature on Hardness
Figure 1(B) shows that an increase in temperature from 120°C to 130°C increases the hardness considerably (batches Bs13) making the chew hard and rocky. At temperature below 120°C, the formed chew did not solidify on cooling and was very soft to be cut with knife (Bs12). At temperature beyond 125°C, the chew became harder and mouthfeel of theˆnal formulation also became poor. Thus, the optimum temperature for making a soft chewable formulation was observed to be 121 125°C. This indicates that melting of sugar is critical and needs to be regulated carefully as heating beyond a certain temperature may result in change in the crystal lattice arrangement with increased crystal strength making them much harder than before. Figure 1 (C) indicates a proportional decrease in grittiness with reduction in the particle size of CC. In addition, the emulsiˆcation time was also found to decrease with reduction in the particle size. This is because with reduced particle size, the surface area increases signiˆcantly which enhances the rate of contact of the drug particles with the surfactant solution. Drug of mesh size 125 mm and 75 mm showed emulsiˆcation time of 30 min and 15 min, respectively. With drug of mesh size 63 mm, grittiness was reduced but no signiˆcant reduction in emulsiˆcation time was observed. Therefore, 75 mm is the optimum size of CC with minimum grittiness and emulsiˆcation time. Further reducing particle size does not add much to the quality of the product. However, it would deˆnitely increase its cost.
EŠect of Particle Size of CC on Grittiness and Emulsiˆcation Time
EŠect of Ratio of GMS/Soy Lecithin on Emulsion Stability
The increase in the ratio of GMS to soy lecithin from 0.3 (Batch Bs5) to 0.5 (Batch Bs2) resulted in a formation of a homogenous and uniform mixture without oil separation (Fig. 1(D) ). However, with further increment in the ratio to 0.8 (Batch Bs6), the oil formed a thin layer on the surface of thê nal formulation, thus destabilizing the mixture and also imparting an oily taste and sticky feel to the chew. This may be due to the fact that with excess quantity of emulsiˆer a phase separation occurred. GMS is used as an emulsiˆer of low HLB value for the preparation of initial w/o emulsion while soy lecithin is used as a stabilizer of theˆnal formulation. As GMS itself imparts some taste to the formulation, therefore, its amount needs to be carefully regulated.
Sugar Free Formulations EŠect of Varying Amount of Sucralose on Sweetness
Sucralose is a high intensity artiˆcial sweetener which if added in excess results in bitter after taste. On increasing the concentration from 0.015％ to 0.025％ w/w, the sweetness of the formulation in batch B2 improved but on further increasing its amount to 0.035％ w/w (Batch B3) resulted in a bitter after taste (Fig. 2(A) ). The concentration of 0.025％ w/w (Batch B2) was found to be optimum for imparting sweetness to the formulation in combination with other sweeteners.
EŠect of Isomalt/MaltisweetMH80 Ratio on Hardness and Mouthfeel
Variation in the ratio of Isomalt/MaltisweetMH80 ratio have an opposite eŠect on the hardness and mouthfeel of the chew (Fig. 2(B) ). Low isomalt maltisweet ratio imparted sweetness, good mouthfeel and low hardness. Higher ratio resulted in conversion of a soft and viscous caramel to comparatively hard mass that could not be cut with knife. This indicates that Isomalt (a polyol in Vol. 129 (2009) powder form) plays an important role in providing hardness while MaltisweetMH80 (high molecular weight polyol with 25％ moisture content) imparts sweetness and improves mouthfeel of theˆnal formulation. From Fig. 2(B) it is clear that Isomalt/Maltitol ratio should be between 1.1 1.3 to obtain a product with optimum hardness and mouthfeel.
EŠect of Sorbitol Concentration on Mouthfeel and Sweetness
Sorbitol, a polyol was added to improve the mouthfeel and impart sweetness to the chew. However due to use of other sweeteners like isomalt, maltisweet and sucralose in the formulation, its concentration needs to be adjusted to achieve acceptable taste. An increase in the concentration of sorbitol from 3％ w/w (Batch B9) to 5％ w/w (Batch B2) was found to improve the mouthfeel and sweetness of the chew. However, at 10％ w/w sorbitol concentration (Batch B10) the sweetness increased to an unacceptable limit (Fig. 2(C) ).
EŠect of Varying Temperature on Hardness
With increase in temperature during preparation, the hardness of the chew increased which may be due to decrease in the moisture content of the formulation. On increasing the temperature from 122°C
(Batch B13) to 124°C (Batch B2), theˆnal formulation changed from viscous, soft caramel to a comparatively harder chewable caramel. However, on further increasing the temperature to 127°C the hardness increased considerably and also aŠected the taste of the formulation. Therefore, the optimum temperature range was found to be between 124°C 126°C
( Fig. 2(D) ).
EŠect of Varying Concentration of GMS on Emulsion Stability
Glycerol monostearate, an emulsiˆ-er is used to stabilize emulsions by preventing phase separation. As its concentration was increased from 0.5％ (Batch B6) to 1％ (Batch B2), the emulsion stability improved. A further increase in concentration of GMS to 1.5％ (Batch B7) did not show any signiˆcant improvement in the stability of the formulation. However, an increase in GMS concentration to 2％ (Batch B8) aŠected the taste of the formulation as GMS itself imparts an undesirable taste to the chew.
The complete evaluation of all the prepared batches revealed that batch Bs2 and B2 were having an optimum hardness, appreciable sweetness and mouthfeel and with low grittiness. Therefore, it can be inferred from the study that the choice and ratio of sugar/sugars (basic component of the formulation) and the processing temperature are the most signiˆcant parameters which require special attention in the development of a SCDDS.
CC Content Analysis
The drug content in Batch Bs2 and B2 were found to be 490 mg 98％ (490 mg) and 99％ (495 mg), respectively, which was within the acceptable limit (±5％).
Drug Dissolution Study
The dissolution study was conducted for Bs2 and B2. As can be seen from the dissolution proˆles (Fig. 3) , the CC was completely dissolved (100％) in 15 min in case of Batch B2 while in case of Batch Bs2, the complete dissolution of CC took place over a period of 30 min. This may be due to the fact that the hardened sugar present in Batch Bs2 dissolves slowly as compared to sugar free tablets which dissolves within few minutes.
Stability Studies
The analysis of the stability samples indicated that the stability of the formulation was dependent on the type of packaging in which the samples were stored. Though the CC content and moisture content did not change in case of the samples packed in aluminium strips (data not shown), the HDPE bottle samples of sugar based chews showed a signiˆcant increase in the moisture level which resulted in distorted and sticky surface texture (Table 4) . This may be due to lack of water resistance capacity of the HDPE bottles in addition to the hygroscopic nature of sugar. This indicates that aluminium packs are preferably better packing material for the SCDDS containing sugar as a major ingredient.
CONCLUSION
A mineral supplement of calcium was successfully formulated into a soft chewable dosage form (sugar based and sugar free) of desired taste, hardness and mouthfeel with low grittiness. The type of emulsifying agent, heating temperature, particle size of the drug, ratio of diŠerent sugars and quantity of sugars were found to have signiˆcant impact on the organoleptic characteristics of the dosage form. The proper selection of packaging material was also found to be important to maintain the long term integrity and stability of the formulation.
